EMD to Use Starpharma's Dendrimers for DNA and siRNA Transfection Research | GenomeWeb
NEW YORK (GenomeWeb News) — EMD Biosciences will use Starpharma’s dendrimers for DNA and siRNA transfection research, EMD said today.
Under the terms of the license and supply agreement, Starpharma’s US subsidiary Dendritic Nanotechnologies will supply EMD with the Priostar technology in exchange for royalties and milestones.
DNT will retain the full rights to use Priostarall for in vivo transfection research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.